Can-Fite BioPharma Ltd. (CANF) income statement
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.51−0.02 (-1.31%)
Close on Nov 18, 2026Market cap $1.98MP/E –Yield –
Can-Fite BioPharma Ltd. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -2456.8%
- Net margin
- -2426.7%
- Return on equity, FY2025
- -178.2%
Financial strength
- Current ratio
- 3.60
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 134.2%
Valuation
- P/E ratio
- –
- Price to sales
- 4.88
- Price to book
- 0.41
- Dividend yield
- –
See a number that looks wrong?